Everest Group Report: Remote Patient Monitoring for Decentralized Clinical Trials


Download the Full Report Now



Everest Group Analyst Report on Remote Patient Monitoring Overview

The Everest Group analysts covered the current state of remote patient monitoring (RPM) to help outline the current industry for the global life sciences community.  They cover how this technology has evolved, what the present state of RPM looks like, the drivers and challenges of RPM technology and the future outlook of RPM.  In addition, they lay out how RPM can be leveraged for decentralized clinical trials and how organizations can develop an RPM roadmap for successful implementation.

Current State of Remote Patient Monitoring (RPM)

Stats show that RPM technology is increasingly being used to help hospitals and clinical researchers develop more nimble and reliable approaches to their remote clinical trials. For example, during the pandemic, remote patient monitoring was leveraged in a variety of ways in 45% of decentralized clinical trials. This far exceeded the next most popular method of decentralized clinical trial monitoring in the pandemic, video visits, which were only leveraged in 37% of clinical trials. There are a variety of types of monitoring covered in the report, along with an overview of the overall RPM architecture to help healthcare providers and technology developers understand the multiple ways they can layer current solutions to deploy a successful RPM approach.

Key Drivers and Challenges for Remote Patient Monitoring Technology

There are multiple benefits to implementing remote patient monitoring and some challenges that keep developers from launching RPM in their decentralized clinical trials. In the Everest Group report, they cover ways to overcome the challenges so that healthcare providers can reap the benefits of a modern RPM solution.

If you can develop a thoughtful implementation roadmap for RPM, you can overcome the most frequent RPM challenges. For example, working with Vivalink, we can help you ensure you get all of the benefits of reduced trial costs and time with higher data integrity without risking your data security or facing trade-offs in patient adherence. Overall, Everest Group recommends that the industry continues to improve their adoption of RPM to accelerate the ability to drive decentralized clinical trials and improve healthcare.

Download the report now to see all of the most common challenges.

The Future of RPM

As the healthcare industry continues to evolve and adopt remote patient monitoring, the future of RPM technology has a strong outlook. The RPM industry continues to see more investments as both healthcare providers and patients expect more continuous and advanced monitoring solutions. The Everest Group quotes Vivalink CEO, Jiang Li, saying “We are continuing to see clinical trials rapidly shift to a decentralized model with remote patient monitoring. A successful RPM solution needs to keep everyone –the technologists, patients, and clinicians – in mind.”

The COVID19 Pandemic was merely a precursor to the extent to which RPM technology can be applied for rapid development and deployment of remote clinical trials and healthcare solutions. RPM enabled biometrics data platforms, data analytics, compliance, and system integration are all top initiatives for innovators in the healthcare industry.

Download the report now to see all of the predictions for the future of RPM.

Building a Successful RPM Roadmap

Everest Group analysts provide a practical, step by step approach to developing a successful RPM roadmap. The first step is to identify a need and the second step is to choose an RPM vendor. RPM developers should consider meeting with top leaders in the industry such as Vivalink to get a consultation on what they can do with their own RPM for clinical use. We can help make sure you have a complete roadmap that includes which devices and sensors to provision, setup and training, and cover the bases with data compliance.